201 related articles for article (PubMed ID: 22135159)
1. Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis.
Wong CM; Wong CC; Lee JM; Fan DN; Au SL; Ng IO
Hepatology; 2012 May; 55(5):1453-61. PubMed ID: 22135159
[TBL] [Abstract][Full Text] [Related]
2. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW
Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210
[TBL] [Abstract][Full Text] [Related]
3. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
[TBL] [Abstract][Full Text] [Related]
4. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
[TBL] [Abstract][Full Text] [Related]
5. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
Petrelli A; Perra A; Schernhuber K; Cargnelutti M; Salvi A; Migliore C; Ghiso E; Benetti A; Barlati S; Ledda-Columbano GM; Portolani N; De Petro G; Columbano A; Giordano S
Oncogene; 2012 Oct; 31(42):4517-26. PubMed ID: 22249248
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
[TBL] [Abstract][Full Text] [Related]
7. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage.
Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y
Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
[TBL] [Abstract][Full Text] [Related]
11. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM
Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893
[TBL] [Abstract][Full Text] [Related]
12. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
13. miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
Fittipaldi S; Vasuri F; Bonora S; Degiovanni A; Santandrea G; Cucchetti A; Gramantieri L; Bolondi L; D'Errico A
Dig Dis Sci; 2017 Sep; 62(9):2397-2407. PubMed ID: 28639131
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein.
Zhou L; He J; Zhang Y
J Int Med Res; 2013 Aug; 41(4):1009-16. PubMed ID: 23766411
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
Peng SY; Lai PL; Pan HW; Hsiao LP; Hsu HC
Oncol Rep; 2008 Apr; 19(4):1045-53. PubMed ID: 18357395
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis.
Gao P; Wong CC; Tung EK; Lee JM; Wong CM; Ng IO
J Hepatol; 2011 Jun; 54(6):1177-84. PubMed ID: 21145831
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis?
Nakata T; Seki N; Miwa S; Kobayashi A; Soeda J; Nimura Y; Kawasaki S; Miyagawa S
Hepatogastroenterology; 2008; 55(84):865-72. PubMed ID: 18705285
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma.
Dai C; Dong QZ; Ren N; Zhu JJ; Zhou HJ; Sun HJ; Wang G; Zhang XF; Xue YH; Jia HL; Ye QH; Qin LX
Cancer Sci; 2011 Mar; 102(3):583-90. PubMed ID: 21219541
[TBL] [Abstract][Full Text] [Related]
20. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]